LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
93 hedge funds and large institutions have $808M invested in La Jolla Pharmaceutical Company in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 95 → 93 (-2)
43% less call options, than puts
Call options by funds: $6.35M | Put options by funds: $11.2M
Holders
93
Holding in Top 10
6
Calls
$6.35M
Puts
$11.2M
Top Buyers
| 1 | +$39.6M | |
| 2 | +$16.9M | |
| 3 | +$8.14M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$6.44M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$6.08M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$7.6M | |
| 3 | -$7.13M | |
| 4 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$4.74M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.46M |